Back to Search
Start Over
Feature selection in clinical proteomics: with great power comes great reproducibility
- Source :
- Drug discovery today. 22(6)
- Publication Year :
- 2016
-
Abstract
- In clinical proteomics, reproducible feature selection is unattainable given the standard statistical hypothesis-testing framework. This leads to irreproducible signatures with no diagnostic power. Instability stems from high P-value variability (p_var), which is inevitable and insolvable. The impact of p_var can be reduced via power increment, for example increasing sample size and measurement accuracy. However, these are not realistic solutions in practice. Instead, workarounds using existing data such as signal boosting transformation techniques and network-based statistical testing is more practical. Furthermore, it is useful to consider other metrics alongside P-values including confidence intervals, effect sizes and cross-validation accuracies to make informed inferences.
- Subjects :
- 0301 basic medicine
Pharmacology
Proteomics
Reproducibility
Accuracy and precision
Boosting (machine learning)
Computer science
Workaround
Decision Making
Reproducibility of Results
Feature selection
computer.software_genre
Confidence interval
03 medical and health sciences
030104 developmental biology
Sample size determination
Drug Discovery
Humans
Data mining
computer
Statistical hypothesis testing
Subjects
Details
- ISSN :
- 18785832
- Volume :
- 22
- Issue :
- 6
- Database :
- OpenAIRE
- Journal :
- Drug discovery today
- Accession number :
- edsair.doi.dedup.....b8b9fe9a83cc3207e907f654a3fedec1